SCOPUS 정보 검색 플랫폼

Volumn 124, Issue 3, 2010, Pages 643-651

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: High cancer incidence at older age

(8) Van Der Kolk, Dorina M a De Bock, Geertruida H a Leegte, Beike K a Schaapveld, Michael b Mourits, Marian J E a De Vries, Jakob a Van Der Hout, Annemieke H a Oosterwijk, Jan C a

a UNIVERSITY MEDICAL CENTER GRONINGEN (Netherlands)

b Integraal Kankercentrum Noord Nederland (Netherlands)

Author keywords

BRCA1; BRCA2; Breast cancer; Contralateral breast cancer; Incidence; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AGE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; CONTRALATERAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NETHERLANDS; OVARY CANCER; PEDIGREE ANALYSIS; PENETRANCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; OVARIAN NEOPLASMS; PEDIGREE; PENETRANCE; PHENOTYPE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 78649322429 PISSN: 01676806 EISSN: 15737217 Source Type: Journal
DOI: 10.1007/s10549-010-0805-3 Document Type: Article

Times cited : (147)

References (30)

1
- 56549111759
- Guideline 'Treatment of breast cancer 2008' (revision)
- 1:STN:280:DC%2BD1cjos1yhtQ%3D%3D 19055257
- H Struikmans JW Nortier EJ Rutgers HM Zonderland M Bontenbal PH Elkhuizen G van Tienhoven VC Tjan-Heijnen T van Vegchel MK Tuut J Benraadt 2008 Guideline 'Treatment of breast cancer 2008' (revision) Ned Tijdschr Geneeskd 152 2507 2511 1:STN:280:DC%2BD1cjos1yhtQ%3D%3D 19055257
- (2008) Ned Tijdschr Geneeskd , vol.152 , pp. 2507-2511
- Struikmans, H.¹ Nortier, J.W.² Rutgers, E.J.³ Zonderland, H.M.⁴ Bontenbal, M.⁵ Elkhuizen, P.H.⁶ Van Tienhoven, G.⁷ Tjan-Heijnen, V.C.⁸ Van Vegchel, T.⁹ Tuut, M.K.¹⁰ Benraadt, J.¹¹

2
- 0030893779
- Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2
- W Burke M Daly J Garber J Botkin MJ Kahn P Lynch A McTiernan K Offit J Perlman G Petersen E Thomson C Varricchio 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium JAMA 277 997 1003 1:STN:280: DyaK2s3ivVSguw%3D%3D 10.1001/jama.277.12.997 9091675 (Pubitemid 27142370)
- (1997) Journal of the American Medical Association , vol.277 , Issue.12 , pp. 997-1003
- Burke, W.¹ Daly, M.² Garber, J.³ Botkin, J.⁴ Kahn, M.J.E.⁵ Lynch, P.⁶ McTiernan, A.⁷ Offit, K.⁸ Perlman, J.⁹ Petersen, G.¹⁰ Thomson, E.¹¹ Varricchio, C.¹²

3
- 58149461571
- Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
- 10.1002/ijc.24038 19035463
- NM van der Velde MJ Mourits HJ Arts J de Vries BK Leegte G Dijkhuis JC Oosterwijk GH de Bock 2009 Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 919 923 10.1002/ijc.24038 19035463
- (2009) Int J Cancer , vol.124 , pp. 919-923
- Van Der Velde, N.M.¹ Mourits, M.J.² Arts, H.J.³ De Vries, J.⁴ Leegte, B.K.⁵ Dijkhuis, G.⁶ Oosterwijk, J.C.⁷ De Bock, G.H.⁸

4
- 0037162110
- Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
- DOI 10.1056/NEJMoa012158
- TR Rebbeck HT Lynch SL Neuhausen SA Narod L Van't Veer JE Garber G Evans C Isaacs MB Daly E Matloff OI Olopade BL Weber 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 1616 1622 10.1056/NEJMoa012158 12023993 (Pubitemid 34755669)
- (2002) New England Journal of Medicine , vol.346 , Issue.21 , pp. 1616-1622
- Rebbeck, T.R.¹ Lynch, H.T.² Neuhausen, S.L.³ Narod, S.A.⁴ Van't Veer, L.⁵ Garber, J.E.⁶ Evans, G.⁷ Isaacs, C.⁸ Daly, M.B.⁹ Matloff, E.¹⁰ Olopade, O.I.¹¹ Weber, B.L.¹²

5
- 0035913275
- Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
- DOI 10.1056/NEJM200107193450301
- H Meijers-Heijboer B van Geel WL van Putten SC Henzen-Logmans C Seynaeve MB Menke-Pluymers CC Bartels LC Verhoog AM van den Ouweland MF Niermeijer CT Brekelmans JG Klijn 2001 Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 345 159 164 1:CAS:528:DC%2BD3MXlslSlt7g%3D 10.1056/NEJM200107193450301 11463009 (Pubitemid 32662123)
- (2001) New England Journal of Medicine , vol.345 , Issue.3 , pp. 159-164
- Meijers-Heijboer, H.¹ Van Geel, B.² Van Putten, W.L.J.³ Henzen-Logmans, S.C.⁴ Seynaeve, C.⁵ Menke-Pluymers, M.B.E.⁶ Bartels, C.C.M.⁷ Verhoog, L.C.⁸ Van Den Ouweland, A.M.W.⁹ Niermeijer, M.F.¹⁰ Brekelmans, C.T.M.¹¹ Klijn, J.G.M.¹²

6
- 0038744296
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
- DOI 10.1086/375033
- A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper N Loman H Olsson O Johannsson A Borg B Pasini P Radice, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130 1:CAS:528:DC%2BD3sXjslagtbg%3D 10.1086/375033 12677558 (Pubitemid 36530000)
- (2003) American Journal of Human Genetics , vol.72 , Issue.5 , pp. 1117-1130
- Antoniou, A.¹ Pharoah, P.D.P.² Narod, S.³ Risch, H.A.⁴ Eyfjord, J.E.⁵ Hopper, J.L.⁶ Loman, N.⁷ Olsson, H.⁸ Johannsson, O.⁹ Borg, A.¹⁰ Pasini, B.¹¹ Radice, P.¹² Manoukian, S.¹³ Eccles, D.M.¹⁴ Tang, N.¹⁵ Olah, E.¹⁶ Anton-Culver, H.¹⁷ Warner, E.¹⁸ Lubinski, J.¹⁹ Gronwald, J.²⁰ more..

7
- 34248170114
- Meta-analysis of BRCA1 and BRCA2 penetrance
- DOI 10.1200/JCO.2006.09.1066
- S Chen G Parmigiani 2007 Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329 1333 10.1200/JCO.2006.09.1066 17416853 (Pubitemid 46706879)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.11 , pp. 1329-1333
- Chen, S.¹ Parmigiani, G.²

8
- 0028843102
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
- 1:STN:280:DyaK2M7is1Whsw%3D%3D 7825587
- DF Easton D Ford DT Bishop 1995 Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Am J Hum Genet 56 265 271 1:STN:280:DyaK2M7is1Whsw%3D%3D 7825587
- (1995) Am J Hum Genet , vol.56 , pp. 265-271
- Easton, D.F.¹ Ford, D.² Bishop, D.T.³

9
- 71049170380
- Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
- DOI 10.1186/1471-2407-8-155
- DG Evans A Shenton E Woodward F Lalloo A Howell ER Maher 2008 Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family BMC Cancer 8 155 10.1186/1471-2407-8-155 18513387 (Pubitemid 352024891)
- (2008) BMC Cancer , vol.8 , pp. 155
- Gareth, D.G.¹ Shenton, A.² Woodward, E.³ Lalloo, F.⁴ Howell, A.⁵ Maher, E.R.⁶

10
- 17344365851
- Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
- DOI 10.1086/301749
- D Ford DF Easton M Stratton S Narod D Goldgar P Devilee DT Bishop B Weber G Lenoir J Chang-Claude H Sobol MD Teare, et al. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676 689 1:CAS:528: DyaK1MXlvFeh 10.1086/301749 9497246 (Pubitemid 28164626)
- (1998) American Journal of Human Genetics , vol.62 , Issue.3 , pp. 676-689
- Ford, D.¹ Easton, D.F.² Stratton, M.³ Narod, S.⁴ Goldgar, D.⁵ Devilee, P.⁶ Bishop, D.T.⁷ Weber, B.⁸ Lenoir, G.⁹ Chang-Claude, J.¹⁰ Sobol, H.¹¹ Teare, M.D.¹² Struewing, J.¹³ Arason, A.¹⁴ Scherneck, S.¹⁵ Peto, J.¹⁶ Rebbeck, T.R.¹⁷ Tonin, P.¹⁸ Neuhausen, S.¹⁹ Barkardottir, R.²⁰ more..

11
- 0142178215
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
- DOI 10.1126/science.1088759
- MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 643 646 1:CAS:528: DC%2BD3sXotlWqt7Y%3D 10.1126/science.1088759 14576434 (Pubitemid 37310920)
- (2003) Science , vol.302 , Issue.5645 , pp. 643-646
- King, M.-C.¹ Marks, J.H.² Mandell, J.B.³

12
- 33644700937
- Survival and prognostic factors in BRCA1-associated breast cancer
- DOI 10.1093/annonc/mdj095
- CT Brekelmans C Seynaeve M Menke-Pluymers HT Bruggenwirth MM Tilanus-Linthorst CC Bartels M Kriege AN van Geel CM Crepin JC Blom H Meijers-Heijboer JG Klijn 2006 Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 17 391 400 1:STN:280: DC%2BD287ht1OksQ%3D%3D 10.1093/annonc/mdj095 16322115 (Pubitemid 43329574)
- (2006) Annals of Oncology , vol.17 , Issue.3 , pp. 391-400
- Brekelmans, C.T.M.¹ Seynaeve, C.² Menke-Pluymers, M.³ Bruggenwirth, H.T.⁴ Tilanus-Linthorst, M.M.A.⁵ Bartels, C.C.M.⁶ Kriege, M.⁷ Van Geel, A.N.⁸ Crepin, C.M.G.⁹ Blom, J.C.¹⁰ Meijers-Heijboer, H.¹¹ Klijn, J.G.M.¹²

13
- 0037181697
- Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
- DOI 10.1016/S0140-6736(02)08434-9
- BG Haffty E Harrold AJ Khan P Pathare TE Smith BC Turner PM Glazer B Ward D Carter E Matloff AE Bale M Alvarez-Franco 2002 Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 1471 1477 10.1016/S0140-6736(02)08434-9 11988246 (Pubitemid 34457765)
- (2002) Lancet , vol.359 , Issue.9316 , pp. 1471-1477
- Haffty, B.G.¹ Harrold, E.² Khan, A.J.³ Pathare, P.⁴ Smith, T.E.⁵ Turner, B.C.⁶ Glazer, P.M.⁷ Ward, B.⁸ Carter, D.⁹ Matloff, E.¹⁰ Bale, A.E.¹¹ Alvarez-Franco, M.¹²

14
- 2942739225
- Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- DOI 10.1200/JCO.2004.04.033
- K Metcalfe HT Lynch P Ghadirian N Tung I Olivotto E Warner OI Olopade A Eisen B Weber J McLennan P Sun WD Foulkes, et al. 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2328 2335 1:CAS:528:DC%2BD2cXpsVWltbs%3D 10.1200/JCO.2004.04.033 15197194 (Pubitemid 41115389)
- (2004) Journal of Clinical Oncology , vol.22 , Issue.12 , pp. 2328-2335
- Metcalfe, K.¹ Lynch, H.T.² Ghadirian, P.³ Tung, N.⁴ Olivotto, I.⁵ Warner, E.⁶ Olopade, O.I.⁷ Eisen, A.⁸ Weber, B.⁹ McLennan, J.¹⁰ Sun, P.¹¹ Foulkes, W.D.¹² Narod, S.A.¹³

15
- 33744988630
- Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
- DOI 10.1200/JCO.2005.02.7888
- LJ Pierce AM Levin TR Rebbeck MA Ben David E Friedman LJ Solin EE Harris DK Gaffney BG Haffty LA Dawson SA Narod IA Olivotto, et al. 2006 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2437 2443 10.1200/JCO.2005.02.7888 16636335 (Pubitemid 46630619)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.16 , pp. 2437-2443
- Pierce, L.J.¹ Levin, A.M.² Rebbeck, T.R.³ Ben-David, M.A.⁴ Friedman, E.⁵ Solin, L.J.⁶ Harris, E.E.⁷ Gaffney, D.K.⁸ Haffty, B.G.⁹ Dawson, L.A.¹⁰ Narod, S.A.¹¹ Olivotto, I.A.¹² Eisen, A.¹³ Whelan, T.J.¹⁴ Olopade, O.I.¹⁵ Isaacs, C.¹⁶ Merajver, S.D.¹⁷ Wong, J.S.¹⁸ Garber, J.E.¹⁹ Weber, B.L.²⁰ more..

16
- 0031860462
- BRCA-associated breast cancer in young women
- 1:STN:280:DyaK1c3ks1artw%3D%3D 9586873
- M Robson T Gilewski B Haas D Levin P Borgen P Rajan Y Hirschaut P Pressman PP Rosen ML Lesser L Norton K Offit 1998 BRCA-associated breast cancer in young women J Clin Oncol 16 1642 1649 1:STN:280:DyaK1c3ks1artw%3D%3D 9586873
- (1998) J Clin Oncol , vol.16 , pp. 1642-1649
- Robson, M.¹ Gilewski, T.² Haas, B.³ Levin, D.⁴ Borgen, P.⁵ Rajan, P.⁶ Hirschaut, Y.⁷ Pressman, P.⁸ Rosen, P.P.⁹ Lesser, M.L.¹⁰ Norton, L.¹¹ Offit, K.¹²

17
- 10844296769
- Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series
- DOI 10.1002/cncr.20728
- M Robson T Svahn B McCormick P Borgen CA Hudis L Norton K Offit 2005 Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series Cancer 103 44 51 10.1002/cncr.20728 15558796 (Pubitemid 39665455)
- (2005) Cancer , vol.103 , Issue.1 , pp. 44-51
- Robson, M.¹ Svahn, T.² McCormick, B.³ Borgen, P.⁴ Hudis, C.A.⁵ Norton, L.⁶ Offit, K.⁷

18
- 0033523268
- Cancer risks in BRCA2 mutation carriers
- The Breast Cancer Linkage Consortium. 10.1093/jnci/91.15.1310
- The Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1310 1316 10.1093/jnci/91.15.1310
- (1999) J Natl Cancer Inst , vol.91 , pp. 1310-1316

19
- 73349132056
- Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
- 10.1200/JCO.2008.19.9430 19858402
- MK Graeser C Engel K Rhiem D Gadzicki U Bick K Kast UG Froster B Schlehe A Bechtold N Arnold S Preisler-Adams C Nestle-Kraemling, et al. 2009 Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers J Clin Oncol 27 5887 5892 10.1200/JCO.2008.19.9430 19858402
- (2009) J Clin Oncol , vol.27 , pp. 5887-5892
- Graeser, M.K.¹ Engel, C.² Rhiem, K.³ Gadzicki, D.⁴ Bick, U.⁵ Kast, K.⁶ Froster, U.G.⁷ Schlehe, B.⁸ Bechtold, A.⁹ Arnold, N.¹⁰ Preisler-Adams, S.¹¹ Nestle-Kraemling, C.¹²

20
- 33645675556
- Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
- 1:CAS:528:DC%2BD28XjsVCgt7Y%3D 10.1002/ijc.21536 16331614
- J Gronwald N Tung WD Foulkes K Offit R Gershoni M Daly C Kim-Sing H Olsson P Ainsworth A Eisen H Saal E Friedman, et al. 2006 Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update Int J Cancer 118 2281 2284 1:CAS:528:DC%2BD28XjsVCgt7Y%3D 10.1002/ijc.21536 16331614
- (2006) Int J Cancer , vol.118 , pp. 2281-2284
- Gronwald, J.¹ Tung, N.² Foulkes, W.D.³ Offit, K.⁴ Gershoni, R.⁵ Daly, M.⁶ Kim-Sing, C.⁷ Olsson, H.⁸ Ainsworth, P.⁹ Eisen, A.¹⁰ Saal, H.¹¹ Friedman, E.¹²

21
- 0032826284
- Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study
- 1:CAS:528:DyaK1MXmsFGktL4%3D 10498392
- JL Hopper MC Southey GS Dite DJ Jolley GG Giles MR McCredie DF Easton DJ Venter 1999 Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study Cancer Epidemiol Biomarkers Prev 8 741 747 1:CAS:528:DyaK1MXmsFGktL4%3D 10498392
- (1999) Cancer Epidemiol Biomarkers Prev , vol.8 , pp. 741-747
- Hopper, J.L.¹ Southey, M.C.² Dite, G.S.³ Jolley, D.J.⁴ Giles, G.G.⁵ McCredie, M.R.⁶ Easton, D.F.⁷ Venter, D.J.⁸

22
- 0034926689
- The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
- 1:CAS:528:DC%2BD3MXktlClu7s%3D 11352856
- JM Satagopan K Offit W Foulkes ME Robson S Wacholder CM Eng SE Karp CB Begg 2001 The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev 10 467 473 1:CAS:528:DC%2BD3MXktlClu7s%3D 11352856
- (2001) Cancer Epidemiol Biomarkers Prev , vol.10 , pp. 467-473
- Satagopan, J.M.¹ Offit, K.² Foulkes, W.³ Robson, M.E.⁴ Wacholder, S.⁵ Eng, C.M.⁶ Karp, S.E.⁷ Begg, C.B.⁸

23
- 0030910022
- The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
- DOI 10.1056/NEJM199705153362001
- JP Struewing P Hartge S Wacholder SM Baker M Berlin M McAdams MM Timmerman LC Brody MA Tucker 1997 The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1401 1408 1:STN:280:DyaK2s3nsVShug%3D%3D 10.1056/NEJM199705153362001 9145676 (Pubitemid 27208598)
- (1997) New England Journal of Medicine , vol.336 , Issue.20 , pp. 1401-1408
- Struewing, J.P.¹ Hartge, P.² Wacholder, S.³ Baker, S.M.⁴ Berlin, M.⁵ McAdams, M.⁶ Timmerman, M.M.⁷ Brody, L.C.⁸ Tucker, M.A.⁹

24
- 0033591850
- Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
- 1:CAS:528:DyaK1MXltVOhu7k%3D 10.1093/jnci/91.14.1241 10413426
- E Warner W Foulkes P Goodwin W Meschino J Blondal C Paterson H Ozcelik P Goss D Allingham-Hawkins N Hamel L Di Prospero V Contiga, et al. 1999 Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91 1241 1247 1:CAS:528: DyaK1MXltVOhu7k%3D 10.1093/jnci/91.14.1241 10413426
- (1999) J Natl Cancer Inst , vol.91 , pp. 1241-1247
- Warner, E.¹ Foulkes, W.² Goodwin, P.³ Meschino, W.⁴ Blondal, J.⁵ Paterson, C.⁶ Ozcelik, H.⁷ Goss, P.⁸ Allingham-Hawkins, D.⁹ Hamel, N.¹⁰ Di Prospero, L.¹¹ Contiga, V.¹²

25
- 33745728357
- A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: Application in a Dutch cancer clinic setting
- 10.1002/humu.20340 16683254
- AH van der Hout AM van den Ouweland RB van der Luijt HJ Gille D Bodmer H Bruggenwirth IM Mulder P van der Vlies P Elfferich MT Huisman AM ten Berge J Kromosoeto, et al. 2006 A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting Hum Mutat 27 654 666 10.1002/humu.20340 16683254
- (2006) Hum Mutat , vol.27 , pp. 654-666
- Van Der Hout, A.H.¹ Van Den Ouweland, A.M.² Van Der Luijt, R.B.³ Gille, H.J.⁴ Bodmer, D.⁵ Bruggenwirth, H.⁶ Mulder, I.M.⁷ Van Der Vlies, P.⁸ Elfferich, P.⁹ Huisman, M.T.¹⁰ Ten Berge, A.M.¹¹ Kromosoeto, J.¹²

26
- 78649321565
- Comprehensive Cancer Center, The Netherlands
- Comprehensive Cancer Center, The Netherlands. http://www.ikcnet.nl

27
- 54249103690
- The risk of cancer in the Netherlands
- 1:STN:280:DC%2BD1cjktlehsg%3D%3D 19009811
- LA Kiemeney FA Lemmers RH Verhoeven KK Aben C Honing J de Nooijer PH Peeters O Visser FA Vlems 2008 The risk of cancer in the Netherlands Ned Tijdschr Geneeskd 152 2233 2241 1:STN:280:DC%2BD1cjktlehsg%3D%3D 19009811
- (2008) Ned Tijdschr Geneeskd , vol.152 , pp. 2233-2241
- Kiemeney, L.A.¹ Lemmers, F.A.² Verhoeven, R.H.³ Aben, K.K.⁴ Honing, C.⁵ De Nooijer, J.⁶ Peeters, P.H.⁷ Visser, O.⁸ Vlems, F.A.⁹

28
- 33846425741
- Phenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening
- DOI 10.1136/jmg.2006.043091
- A Smith A Moran MC Boyd M Bulman A Shenton L Smith R Iddenden ER Woodward F Lalloo ER Maher DG Evans 2007 Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening J Med Genet 44 10 15 1:CAS:528:DC%2BD2sXhvVGisro%3D 10.1136/jmg.2006.043091 17079251 (Pubitemid 46142833)
- (2007) Journal of Medical Genetics , vol.44 , Issue.1 , pp. 10-15
- Smith, A.¹ Moran, A.² Boyd, M.C.³ Bulman, M.⁴ Shenton, A.⁵ Smith, L.⁶ Iddenden, R.⁷ Woodward, E.R.⁸ Lalloo, F.⁹ Maher, E.R.¹⁰ Evans, D.G.R.¹¹

29
- 85010791733
- A combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
- 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D 10.1186/bcr658 14680495
- ME Robson PO Chappuis J Satagopan N Wong J Boyd JR Goffin C Hudis D Roberge L Norton LR Begin K Offit WD Foulkes 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 R8 R17 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D 10.1186/bcr658 14680495
- (2004) Breast Cancer Res , vol.6
- Robson, M.E.¹ Chappuis, P.O.² Satagopan, J.³ Wong, N.⁴ Boyd, J.⁵ Goffin, J.R.⁶ Hudis, C.⁷ Roberge, D.⁸ Norton, L.⁹ Begin, L.R.¹⁰ Offit, K.¹¹ Foulkes, W.D.¹²

30
- 33645309606
- Surveillance of women at high risk for hereditary ovarian cancer is inefficient
- 1:STN:280:DC%2BD287mt1eksA%3D%3D 10.1038/sj.bjc.6603015 16495917
- AL Oei LF Massuger J Bulten MJ Ligtenberg N Hoogerbrugge JA de Hullu 2006 Surveillance of women at high risk for hereditary ovarian cancer is inefficient Br J Cancer 94 814 819 1:STN:280:DC%2BD287mt1eksA%3D%3D 10.1038/sj.bjc.6603015 16495917
- (2006) Br J Cancer , vol.94 , pp. 814-819
- Oei, A.L.¹ Massuger, L.F.² Bulten, J.³ Ligtenberg, M.J.⁴ Hoogerbrugge, N.⁵ De Hullu, J.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.